Changes in lipid metabolism during 12 months of treatment with two oral contraceptives containing 30 μg ethinylestradiol and 75 μg gestodene or 150 μg desogestrel

This publication has 24 references indexed in Scilit:

• Alterations in the serum levels of gestodene and SHBG during 12 cycles of treatment with 30 μg ethinylestradiol and 75 μg gestodene
  Contraception, 1988
• Serum lipid profile in women using levonorgestrel contraceptive implant, Norplant(R)-2
  Contraception, 1988
• Analysis of plasma lipoproteins by ultracentrifugation in a new fixed angle rotor: Evaluation of a phosphotungstic acid/MgCl2 precipitation and a quantitative lipoprotein electrophoresis assay
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1986
• Progestins and oral contraceptive-induced lipoprotein changes: A prospective study
  Contraception, 1986
• Chylomicron and very low-density lipoprotein apolipoprotein B metabolism: Mechanism of the response to stanozolol in a patient with severe hypertriglyceridemia
  Metabolism, 1984
• The Effects of Estrogen Administration on Plasma Lipoprotein Metabolism in Premenopausal Females
  Journal of Clinical Endocrinology & Metabolism, 1983
• Effect of Estrogen/Progestin Potency on Lipid/Lipoprotein Cholesterol
  New England Journal of Medicine, 1983
• High Density Lipoprotein-2 and Hepatic Lipase: Reciprocal Changes Produced by Estrogen and Norgestrel*
  Journal of Clinical Endocrinology & Metabolism, 1982
• Effects of estrogens and progestogens on lipid metabolism
  American Journal of Obstetrics and Gynecology, 1982
• Different effects of two progestins on plasma high density lipoprotein (HDL2) and postheparin plasma hepatic lipase activity
  Atherosclerosis, 1981